BackgroundCheck.run
Search For

Dong Hyun Lim, 5511809 29Th Ave, Flushing, NY 11354

Known as:
Dong H Lim Donghyun Lim Dong L Hyun Lim Donghyun
Related to:
Banya B Lim 54

Dong Lim Phones & Addresses

11809 29Th Ave, Flushing, NY 11354   

1592 208Th St #1, Flushing, NY 11360    718-2791847   

14465 27Th Ave, Flushing, NY 11354    718-5392393   

Bayside, NY   

Milford, CT   

Bridgeport, CT   

Queens, NY   

Get Report
Control this profile

Mentions for Dong Hyun Lim

Dong Lim resumes & CV records

Resumes

Dong Lim Photo 38

Dong Lim

Dong Lim Photo 39

Intern - Administration Team

Work:

Intern - Administration Team
Dong Lim Photo 40

Dong Hae Lim

Dong Lim Photo 41

Dong Lim

Industry:
Health, Wellness And Fitness
Work:
Massage Therapist/Teacher
Cmt
Dong Lim Photo 42

Dong Yul Lim

Publications & IP owners

Us Patents

Cytochrome P450 Inhibitors And Uses Thereof

US Patent:
8513291, Aug 20, 2013
Filed:
Jun 1, 2011
Appl. No.:
13/700730
Inventors:
Bijoy Panicker - Holtsville NY, US
Lambertus J. W. M. Oehlen - Westbury NY, US
James G. Tarrant - Lindenhurst NY, US
Dong Sung Lim - Fair Lawn NJ, US
Xiaokang Zhu - Oakland Gardens NY, US
Dawoon Jung - Tenafly NJ, US
Rama K. Mishra - Chicago IL, US
Assignee:
Angion Biomedica Corp. - Uniondale NY
International Classification:
C07D 277/66
C07D 277/74
C07D 277/82
A61K 31/428
US Classification:
514367, 548163, 548164, 548165, 5483461, 548152
Abstract:
The present invention provides compounds having the general structural formula (I) and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Small Molecule Inhibitors Of Parp Activity

US Patent:
8513433, Aug 20, 2013
Filed:
Jul 2, 2010
Appl. No.:
13/381856
Inventors:
Bijoy Panicker - Holbrook NY, US
Dong Sung Lim - Rochelle Park NJ, US
David E. Smith - Sea Cliff NY, US
Assignee:
Angion Biomedica Corp. - Uniondale NY
International Classification:
A61K 31/4184
C07D 403/04
C07D 401/04
US Classification:
5483061, 540476, 540593, 546144, 546165, 514183, 51421301, 514307, 514314, 514394
Abstract:
Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.

Small Molecule Inhibitors Of Parp Activity

US Patent:
2011009, Apr 28, 2011
Filed:
Nov 19, 2009
Appl. No.:
12/592163
Inventors:
Bijoy Panicker - Holbrook NY, US
Dawoon Jung - Tenafly NJ, US
Xiaokang Zhu - Oakland Gardens NY, US
David E. Smith - Sea Cliff NY, US
Dong Sung Lim - Rochelle Park NJ, US
International Classification:
A61K 31/502
C07D 237/32
A61P 25/16
A61P 9/10
A61P 25/28
A61P 9/12
A61P 3/10
A61P 13/12
A61P 1/16
US Classification:
514248, 544237
Abstract:
Componds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such componds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.

Small Molecule Inhibitors Of Parp Activity

US Patent:
2013030, Nov 14, 2013
Filed:
Jul 14, 2013
Appl. No.:
13/941510
Inventors:
Bijoy Panicker - Holbrook NY, US
Dong Sung Lim - Fair Lawn NJ, US
David E. Smith - Sea Cliff NY, US
International Classification:
C07D 403/04
C07D 401/04
US Classification:
514307, 546144, 435184, 5483051, 514394, 546167, 514314
Abstract:
Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.

Cytochrome P450 Inhibitors And Uses Thereof

US Patent:
2014001, Jan 16, 2014
Filed:
Jul 4, 2013
Appl. No.:
13/935517
Inventors:
Bijoy Panicker - Holbrook NY, US
Dong Sung Lim - Fair Lawn NJ, US
Rama K. Mishra - Chicago IL, US
Lambertus J.W.M. Oehlen - Westbury NY, US
James G. Tarrant - Lindenhurst NY, US
Xiaokang Zhu - Oakland Gardens NY, US
Dawoon Jung - Tenafly NJ, US
Assignee:
ANGION BIOMEDICA CORP - Uniondale NY
International Classification:
C07D 417/12
US Classification:
514367, 548161
Abstract:
The present invention provides compounds having the general structural formula (I)and pharmaceutically acceptable derivatives thereof, as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases involving fibrosis and proliferation, and where anti-fibrotic or anti-proliferative activity is beneficial.

Ethynylheterocycles As Rho-Associated Coiled-Coil Kinase (Rock) Inhibitors

US Patent:
2022028, Sep 8, 2022
Filed:
Jul 21, 2020
Appl. No.:
17/629061
Inventors:
- Uniondale NY, US
Satish Kumar Sakilam - Harrison NJ, US
Satishkumar Gadhiya - Jamaica NY, US
Dong Sung Lim - Fair Lawn NJ, US
Yao Zong - Port Washington NY, US
Shashikanth Ponnala - Secaucus NJ, US
Ying Zhang - Glen Cove NY, US
Dawoon Jung - Tenafly NJ, US
Lambertus J.W.M. Oehlen - Westbury NY, US
International Classification:
C07D 401/14
C07D 403/14
C07D 471/04
C07D 487/04
C07D 417/14
C07F 9/6558
Abstract:
The present invention provides compounds having formula (I): and pharmaceutically acceptable salts thereof, wherein Cy1, Cy2, Cy3, R, R, R, and Rare as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which inhibiting ROCK1, ROCK2, or ROCK1/2 has a therapeutically useful role.

Solid Forms Of (E)-3-[2-(2-Thienyl)Vinyl]-1H-Pyrazole

US Patent:
2021007, Mar 18, 2021
Filed:
Dec 1, 2020
Appl. No.:
17/108462
Inventors:
- Uniondale NY, US
Satish Kumar Sakilam - Harrison NJ, US
Dong Sung Lim - Fair Lawn NJ, US
International Classification:
C07D 409/06
Abstract:
The present disclosure provides solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole, compositions thereof, and methods of making and using the same.

Solid Forms Of (E)-3-[2-(2-Thienyl)Vinyl]-1H-Pyrazole

US Patent:
2020036, Nov 26, 2020
Filed:
Jul 29, 2020
Appl. No.:
16/942182
Inventors:
- Uniondale NY, US
Satish Kumar Sakilam - Harrison NJ, US
Dong Sung Lim - Fair Lawn NJ, US
International Classification:
C07D 409/06
Abstract:
The present disclosure provides solid forms of (E)-3-[2-(2-thienyl)vinyl]-1H-pyrazole, compositions thereof, and methods of making and using the same.

Possible Relatives

David B Lim  Cyril P Lim  Dae Q Lim  Deanna R Lim  Dale L Lim  Debbie M Lim  Damon W Lim  Dong J Jun  Dong Jung  Dong Kang 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.